Inbrain Neuroelectronics is a privately held company tracked for investment-relevant business and technology developments.
This slot renders the company's funding history: dates, rounds, amounts, valuations and lead investors once populated in data/funding-rounds.json.
Inbrain's graphene-based neurostimulation devices achieve higher resolution than Neuralink, have already been implanted in humans for Parkinson's and epilepsy, and are led by ex-Medtronic neurostimulation head Carolina Aguilar, creating a clear commercial pathway.